Elsevier

Clinical Biochemistry

Volume 25, Issue 3, June 1992, Pages 223-234
Clinical Biochemistry

Autoantibody specificity in drug-induced lupus and neutrophil-mediated metabolism of lupus-inducing drugs

https://doi.org/10.1016/0009-9120(92)90354-UGet rights and content

A long-term side effect of therapy with a variety of drugs is a syndrome resembling the idiopathic autoimmune disease, systemic lupus erythematosus. Essentially all patients with drug-induced lupus display autoantibodies to nuclear histone components whose specificity appears to be related to the higher order structure of histones existing in chromatin. IgG antibodies to H1 and the (H2A-H2B)—DNA complex were observed in most patients with lupus induced by procainamide, hydralazine, and quinidine, whereas the H3-H4 tetramer, comprising half the mass of the nucleosome core particle, was largely nonantigenic. IgM antibodies to (H2A-H2B)-containing chromatin subunits were common also. IgM reactivity was observed with the DNA-free H3-H4 tetramer and with H1, especially in hydralazine-induced lupus. These results suggest that IgM antihistone antibodies may result from autoimmunization with a nonnative form of chromatin, whereas IgG antibodies may be selected for reactivity with H1 and a native form of the (H2A-H2B)-DNA subunit of the nucleosome.

The chemical basis for induction of autoimmunity by drugs is unclear because lupus-inducing drugs do not have a common structural feature or biological activity nor are they capable of specific reactions with histones, the principal target antigen. However, in the presence of activated neutrophils, procainamide is transformed metabolically to the cytotoxic procainamide—hydroxylamine. Mixing experiments and cell-free studies demonstrated that procainamide was cooxidized with H2O2 by myeloperoxidase released when neutrophils undergo the respiratory burst and degranulation reactions. Preliminary results indicate other lupus-inducing drugs are also biotransformed by this mechanism suggesting that a common denominator linking these drugs may be the capacity to be oxidized to reactive metabolites by the action of activated phagocytic cells.

References (45)

  • WeinsteinA

    Drug-Induced lupus erythematosus

    Prog Clin Immunol

    (1980)
  • LeeSL et al.

    Drug-induced systemic lupus erythematosus: A critical review

    Semin Arthritis Rheum

    (1975)
  • FritzlerMJ et al.

    Antibodies to histones in drug-induced and idiopathic lupus erythematosus

    J Clin Invest

    (1978)
  • RubinRL et al.

    Procainamide elicits a selective autoantibody immune response

    Clin Exp Immunol

    (1986)
  • GohillJ et al.

    Antibodies from patients with drug-induced and idiopathic lupus erythematosus react with epitopes restricted to the amino and carboxyl termini of histone

    J Immunol

    (1985)
  • PortanovaJP et al.

    Anti-histone antibodies in idiopathic and drug-induced lupus recognize distinct intrahistone regions

    J Immunol

    (1987)
  • CraftJE et al.

    Autoantigenic histone epitopes: A comparison between procainamide- and hydralazine-induced lupus

    Arthritis Rheum

    (1987)
  • BernsteinRM et al.

    Patterns of antihistone antibody specificity in systemic rheumatic disease

    Arthritis Rheum

    (1985)
  • HardinJA et al.

    Antibodies to histones in systemic lupus erythematosus: Localization of prominent autoantigens on histones H1 and H2B

  • GodfreyJE et al.

    Spectropolarimetric analysis of the core histone octamer and its subunits

    Biochemistry

    (1990)
  • BurlingameRW et al.

    Drug-induced anti-histone autoantibodies display two patterns of reactivity with substructures of chromatin

    J Clin Invest

    (1991)
  • WoodhouseKW et al.

    Hepatic drug metabolsim and ageing

    Br Med Bull

    (1990)
  • Cited by (20)

    • Drug-Induced Lupus Mechanisms

      2011, Systemic Lupus Erythematosus
    • Drug-Induced Lupus Mechanisms

      2010, Systemic Lupus Erythematosus, Fifth Edition
    • Pathophysiology of drug-induced lupus

      2004, Systemic Lupus Erythematosus, Fourth Edition
    View all citing articles on Scopus
    View full text